The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMediumUpdated•Originally published 29 April 2026•Updated 30 April 2026•

1 min read

NeoGenomics and Northern Oil and Gas Report Q1 Results with Revenue Beats

Key Facts

1NeoGenomics reported Q1 adjusted EPS of $0.01, matching analyst estimates.

2Northern Oil and Gas reported Q1 revenue of $539.9 million, exceeding the $511.4 million estimate.

about 1 month ago

Version History

Version 1about 1 month ago

What changed: Added Q1 earnings results and future revenue guidance for DexCom (DXCM) to the report.

NeoGenomics and Northern Oil and Gas reported positive Q1 financial results, with NeoGenomics posting an adjusted EPS of $0.01 in line with estimates and 2026 revenue guidance of $797 million to $803 million. Northern Oil and Gas delivered a revenue beat at $539.9 million, exceeding the $511.4 million forecast. Adding to the healthcare sector momentum, DexCom announced Q1 revenue of $1.19 billion and an adjusted EPS of $0.56. Furthermore, DexCom established a robust 2026 revenue target between $5.16 billion and $5.25 billion. These combined results highlight operational resilience across the healthcare and energy industries, bolstering investor confidence in long-term growth trajectories. Markets continue to monitor how these firms sustain momentum amid broader economic challenges.